$378 Million is the total value of Parkman Healthcare Partners LLC's 84 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 39.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $18,407,000 | +26.4% | 236,954 | -9.5% | 4.87% | +18.8% |
| DHR | Buy | DANAHER CORPORATION | $13,998,000 | +58.3% | 65,008 | +30.0% | 3.71% | +48.8% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $12,745,000 | -14.0% | 132,544 | +9.1% | 3.38% | -19.2% |
| NTRA | Buy | NATERA INC | $12,654,000 | +69.0% | 175,161 | +16.7% | 3.35% | +58.9% |
| DXCM | Sell | DEXCOM INC | $12,189,000 | -7.7% | 29,569 | -9.2% | 3.23% | -13.2% |
| HUM | Sell | HUMANA INC | $10,972,000 | -5.7% | 26,509 | -11.6% | 2.90% | -11.4% |
| MRK | Buy | MERCK & CO. INC | $10,438,000 | +7.3% | 125,834 | +0.0% | 2.76% | +0.8% |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $9,780,000 | +17.9% | 122,531 | +2.1% | 2.59% | +10.9% |
| TPTX | Buy | TURNING POINT THERAPEUTICS I | $9,639,000 | +35.3% | 110,335 | +0.0% | 2.55% | +27.2% |
| CRL | Buy | CHARLES RIV LABS INTL INC | $9,059,000 | +29.9% | 40,005 | +0.0% | 2.40% | +22.1% |
| AXNX | Sell | AXONICS MODULATION TECHNOLOG | $9,032,000 | +6.3% | 176,950 | -26.9% | 2.39% | -0.0% |
| VCEL | Sell | VERICEL CORP | $8,346,000 | +27.1% | 450,400 | -5.2% | 2.21% | +19.4% |
| IQV | Buy | IQVIA HLDGS INC | $8,277,000 | +22.8% | 52,508 | +10.5% | 2.19% | +15.4% |
| MASI | New | MASIMO CORP | $8,262,000 | – | 35,000 | +100.0% | 2.19% | – |
| SILK | Buy | SILK RD MED INC | $8,066,000 | +60.5% | 120,015 | +0.0% | 2.14% | +50.8% |
| CTLT | Sell | CATALENT INC | $7,711,000 | +10.7% | 90,016 | -5.2% | 2.04% | +4.1% |
| PODD | Buy | INSULET CORP | $7,690,000 | +126.2% | 32,503 | +85.7% | 2.04% | +112.5% |
| IMUX | Buy | IMMUNIC INC | $7,428,000 | +337.7% | 400,023 | +185.7% | 1.97% | +311.5% |
| GNMK | Sell | GENMARK DIAGNOSTICS INC | $6,819,000 | -42.1% | 480,199 | -40.0% | 1.81% | -45.5% |
| ABBV | Buy | ABBVIE INC | $6,570,000 | -10.8% | 75,008 | +0.0% | 1.74% | -16.1% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $6,547,000 | -22.1% | 21,001 | -26.3% | 1.73% | -26.8% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $6,123,000 | +5.5% | 22,501 | +12.5% | 1.62% | -0.9% |
| DRNA | Buy | DICERNA PHARMACEUTICALS INC | $5,862,000 | -23.3% | 325,863 | +8.3% | 1.55% | -27.9% |
| ITMR | Buy | ITAMAR MED LTDsponsored ads | $5,735,000 | +9.9% | 280,700 | +0.0% | 1.52% | +3.3% |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $5,722,000 | – | 50,000 | +100.0% | 1.52% | – |
| XLRN | Sell | ACCELERON PHARMA INC | $5,628,000 | +2.7% | 50,016 | -13.0% | 1.49% | -3.4% |
| KOD | Buy | KODIAK SCIENCES INC | $5,491,000 | +55.6% | 92,733 | +42.2% | 1.45% | +46.3% |
| Buy | TRILLIUM THERAPEUTICS INC | $5,330,000 | +119.6% | 375,063 | +25.0% | 1.41% | +106.3% | |
| NUAN | Buy | NUANCE COMMUNICATIONS INC | $5,313,000 | +67.9% | 160,075 | +28.0% | 1.41% | +57.7% |
| IMVT | Buy | IMMUNOVANT INC | $5,284,000 | +73.4% | 150,151 | +20.0% | 1.40% | +63.1% |
| SPNE | Buy | SEASPINE HLDGS CORP | $5,274,000 | +105.0% | 368,813 | +50.1% | 1.40% | +92.6% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $5,146,000 | -30.5% | 464,825 | -21.3% | 1.36% | -34.6% |
| ICAD | Sell | ICAD INC | $5,125,000 | -29.3% | 581,752 | -19.8% | 1.36% | -33.5% |
| GWPH | Sell | GW PHARMACEUTICALS PLCads | $4,868,000 | -66.9% | 50,000 | -58.3% | 1.29% | -68.9% |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $4,736,000 | +72.2% | 1,842,661 | +8.6% | 1.25% | +61.8% |
| KRMD | Sell | REPRO MED SYS INC | $4,557,000 | -29.7% | 631,226 | -12.6% | 1.21% | -33.9% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $4,494,000 | -15.4% | 30,863 | -13.9% | 1.19% | -20.5% |
| SDC | New | SMILEDIRECTCLUB INC | $4,205,000 | – | 360,000 | +100.0% | 1.11% | – |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $4,029,000 | +1.8% | 235,038 | +46.9% | 1.07% | -4.3% |
| ZYME | New | ZYMEWORKS INC | $3,959,000 | – | 85,000 | +100.0% | 1.05% | – |
| CDMO | Buy | AVID BIOSERVICES INC | $3,690,000 | +349.5% | 484,247 | +287.4% | 0.98% | +322.9% |
| KDMN | Buy | KADMON HLDGS INC | $3,431,000 | -7.6% | 875,150 | +20.7% | 0.91% | -13.2% |
| ATEC | Buy | ALPHATEC HLDGS INC | $2,999,000 | +49.6% | 451,672 | +5.9% | 0.79% | +40.5% |
| INFU | Buy | INFUSYSTEM HLDGS INC | $2,986,000 | +20.1% | 232,935 | +8.1% | 0.79% | +12.8% |
| IDXX | New | IDEXX LABS INC | $2,948,000 | – | 7,500 | +100.0% | 0.78% | – |
| MTEM | Sell | MOLECULAR TEMPLATES INC | $2,926,000 | -38.1% | 267,938 | -21.9% | 0.78% | -41.8% |
| ETNB | New | 89BIO INC | $2,823,000 | – | 110,000 | +100.0% | 0.75% | – |
| BBIO | Buy | BRIDGEBIO PHARMA INC | $2,823,000 | +15.1% | 75,228 | +0.0% | 0.75% | +8.1% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $2,751,000 | -35.9% | 800,740 | -11.1% | 0.73% | -39.8% |
| MRSN | Sell | MERSANA THERAPEUTICS INC | $2,608,000 | -55.4% | 140,066 | -44.0% | 0.69% | -58.1% |
| ARWR | New | ARROWHEAD PHARMACEUTICALS IN | $2,584,000 | – | 60,000 | +100.0% | 0.68% | – |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $2,494,000 | -24.2% | 35,010 | -12.5% | 0.66% | -28.8% |
| SDGR | Buy | SCHRODINGER INC | $2,376,000 | +72.9% | 50,000 | +233.3% | 0.63% | +62.5% |
| KALA | Buy | KALA PHARMACEUTICALS INC | $2,325,000 | -19.6% | 310,053 | +12.7% | 0.62% | -24.3% |
| STXS | Sell | STEREOTAXIS INC | $2,305,000 | -22.7% | 643,813 | -3.7% | 0.61% | -27.4% |
| MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $2,162,000 | -61.8% | 18,211 | -63.6% | 0.57% | -64.1% |
| STRO | New | SUTRO BIOPHARMA INC | $2,111,000 | – | 210,000 | +100.0% | 0.56% | – |
| AVRO | Sell | AVROBIO INC | $2,091,000 | -37.1% | 160,624 | -15.7% | 0.55% | -40.9% |
| EIDX | Buy | EIDOS THERAPEUTICS INC | $2,076,000 | +6.0% | 41,091 | +0.0% | 0.55% | -0.4% |
| AUPH | Buy | AURINIA PHARMACEUTICALS INC | $1,919,000 | -9.4% | 130,312 | +0.0% | 0.51% | -14.8% |
| NVAX | Sell | NOVAVAX INC | $1,896,000 | -43.1% | 17,500 | -56.2% | 0.50% | -46.5% |
| NEPH | Sell | NEPHROS INC | $1,745,000 | -17.3% | 241,411 | -4.0% | 0.46% | -22.2% |
| MGTX | Sell | MEIRAGTX HLDGS PLC | $1,731,000 | +2.4% | 130,763 | -3.1% | 0.46% | -3.8% |
| MSON | Buy | MISONIX INC | $1,591,000 | -9.8% | 135,596 | +4.3% | 0.42% | -15.3% |
| CSTL | Buy | CASTLE BIOSCIENCES INC | $1,544,000 | +63.9% | 30,003 | +20.0% | 0.41% | +54.3% |
| AXGN | New | AXOGEN INC | $1,454,000 | – | 125,000 | +100.0% | 0.38% | – |
| SURF | Buy | SURFACE ONCOLOGY INC | $1,380,000 | +68.3% | 200,019 | +60.0% | 0.36% | +58.0% |
| INOV | New | INOVALON HLDGS INC | $1,323,000 | – | 50,000 | +100.0% | 0.35% | – |
| PROF | New | PROFOUND MED CORP | $1,235,000 | – | 70,000 | +100.0% | 0.33% | – |
| QDEL | Sell | QUIDEL CORP | $1,097,000 | -18.3% | 5,001 | -16.6% | 0.29% | -23.3% |
| RAPT | Sell | RAPT THERAPEUTICS INC | $966,000 | -16.8% | 30,010 | -25.0% | 0.26% | -21.7% |
| Sell | CATABASIS PHARMACEUTICALS IN | $901,000 | -9.9% | 145,501 | -6.4% | 0.24% | -15.2% | |
| CBIO | Sell | CATALYST BIOSCIENCES INC | $896,000 | -29.1% | 208,478 | -3.1% | 0.24% | -33.4% |
| DVAX | New | DYNAVAX TECHNOLOGIES CORP | $864,000 | – | 200,000 | +100.0% | 0.23% | – |
| MNKD | Sell | MANNKIND CORP | $660,000 | -31.5% | 351,230 | -36.3% | 0.18% | -35.7% |
| FBRX | New | FORTE BIOSCIENCES INC | $606,000 | – | 12,500 | +100.0% | 0.16% | – |
| EDAP | New | EDAP TMS S Asponsored adr | $575,000 | – | 125,000 | +100.0% | 0.15% | – |
| GDRX | New | GOODRX HLDGS INC | $556,000 | – | 10,000 | +100.0% | 0.15% | – |
| BCEL | New | ATRECA INC | $489,000 | – | 35,000 | +100.0% | 0.13% | – |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $489,000 | -44.0% | 116,158 | -7.9% | 0.13% | -47.6% |
| APRE | Sell | APREA THERAPEUTICS INC | $482,000 | -69.0% | 20,042 | -49.9% | 0.13% | -70.8% |
| ARPO | New | AERPIO PHARMACEUTICALS INC | $450,000 | – | 300,000 | +100.0% | 0.12% | – |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $443,000 | -0.4% | 30,005 | +0.0% | 0.12% | -6.4% |
| OM | New | OUTSET MED INC | $350,000 | – | 7,000 | +100.0% | 0.09% | – |
| CLPT | Exit | CLEARPOINT NEURO INC | $0 | – | -25,078 | -100.0% | -0.02% | – |
| MRNS | Exit | MARINUS PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -0.07% | – |
| APYX | Exit | APYX MED CORP | $0 | – | -70,497 | -100.0% | -0.11% | – |
| MRNA | Exit | MODERNA INC | $0 | – | -10,000 | -100.0% | -0.18% | – |
| MBIO | Exit | MUSTANG BIO INC | $0 | – | -303,376 | -100.0% | -0.27% | – |
| PIRS | Exit | PIERIS PHARMACEUTICALS INC | $0 | – | -458,843 | -100.0% | -0.40% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -25,000 | -100.0% | -0.52% | – |
| IRMD | Exit | IRADIMED CORP | $0 | – | -94,717 | -100.0% | -0.62% | – |
| KPTI | Exit | KARYOPHARM THERAPEUTICS INC | $0 | – | -120,802 | -100.0% | -0.64% | – |
| AKRO | Exit | AKERO THERAPEUTICS INC | $0 | – | -95,000 | -100.0% | -0.67% | – |
| HAE | Exit | HAEMONETICS CORP | $0 | – | -30,147 | -100.0% | -0.76% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -37,500 | -100.0% | -1.80% | – |
| XBI | Exit | SPDR SER TRput | $0 | – | -75,000 | -100.0% | -2.36% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEXCOM INC | 16 | Q3 2023 | 6.3% |
| ACLARIS THERAPEUTICS INC | 16 | Q3 2023 | 10.0% |
| XENON PHARMACEUTICALS INC | 16 | Q3 2023 | 3.3% |
| NATERA INC | 16 | Q3 2023 | 3.4% |
| AVID BIOSERVICES INC | 15 | Q3 2023 | 2.9% |
| SCHRODINGER INC | 15 | Q3 2023 | 4.2% |
| REPRO MED SYS INC | 15 | Q2 2023 | 2.0% |
| MANNKIND CORP | 15 | Q3 2023 | 1.6% |
| IQVIA HLDGS INC | 14 | Q1 2023 | 4.6% |
| INSULET CORP | 14 | Q3 2023 | 2.9% |
View Parkman Healthcare Partners LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| PLUS THERAPEUTICS, INC. | February 13, 2023 | 583,467 | 1.7% |
View Parkman Healthcare Partners LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Parkman Healthcare Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.